Selected article for: "frequency rate and score symptom duration"
Author: Lee, Chang-Seop; Lee, Ju-Hyung; Oh, Mira; Choi, Kyung-Min; Jeong, Mi Ran; Park, Jong-Dae; Kwon, Dae Young; Ha, Ki-Chan; Park, Eun-Ock; Lee, Nuri; Kim, Sun-Young; Choi, Eun-Kyung; Kim, Min-Gul; Chae, Soo-Wan
Title: Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial
  • Document date: 2012_12_7
    • ID: v07crluc_34
    Snippet: The frequency rate of ARI was significantly lower in the KRG group than in the placebo group in this study. The symptom duration was short and the symptom score was lower in KRG group than placebo group. However, the statistical significance was not observed. Regarding the safety of KRG, there were no specific clinical and laboratory side effects after 12 weeks for the healthy subjects......
    Document: The frequency rate of ARI was significantly lower in the KRG group than in the placebo group in this study. The symptom duration was short and the symptom score was lower in KRG group than placebo group. However, the statistical significance was not observed. Regarding the safety of KRG, there were no specific clinical and laboratory side effects after 12 weeks for the healthy subjects.

    Search related documents:
    Co phrase search for related documents
    • ARI frequency rate and laboratory clinical: 1
    • ARI frequency rate and symptom duration: 1, 2
    • ARI frequency rate and symptom score: 1, 2
    • frequency rate and KRG group: 1
    • frequency rate and laboratory clinical: 1, 2, 3
    • frequency rate and placebo group: 1, 2
    • frequency rate and statistical significance: 1, 2
    • frequency rate and symptom duration: 1, 2, 3
    • frequency rate and symptom score: 1, 2, 3, 4
    • KRG group and placebo group: 1, 2, 3, 4, 5, 6, 7, 8
    • KRG group and statistical significance: 1
    • KRG group and study placebo group: 1
    • KRG group and symptom duration: 1, 2, 3
    • KRG group and symptom score: 1, 2
    • laboratory clinical and specific laboratory clinical: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • laboratory clinical and statistical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • laboratory clinical and study placebo group: 1, 2, 3
    • laboratory clinical and symptom duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • laboratory clinical and symptom score: 1, 2, 3, 4